Dr Ciaran Kohli-Lynch
- Visiting Research Assistant (School of Health & Wellbeing)
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
Kohli-Lynch, C. N., Lewsey, J. , Boyd, K. A. , French, D. D., Jordan, N., Moran, A. E., Sattar, N. , Preiss, D. and Briggs, A. H. (2022) Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease. Circulation, 145(17), pp. 1312-1323. (doi: 10.1161/CIRCULATIONAHA.121.057631) (PMID:35249370) (PMCID:PMC9022692)
Xin, Y. , Gray, E., Robles-Zurita, J. A., Haghpanahan, H. , Heggie, R., Kohli-Lynch, C., Briggs, A. , McAllister, D. A. , Lawson, K. D. and Lewsey, J. (2022) From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R. Applied Health Economics and Health Policy, 20(2), pp. 149-158. (doi: 10.1007/s40258-021-00684-y) (PMID:34671930)
Kohli-Lynch, C., Thanassoulis, G., Moran, A. and Sniderman, A. D. (2020) The clinical utility of apoB versus LDL-C/non-HDL-C. Clinica Chimica Acta, 508, pp. 103-108. (doi: 10.1016/j.cca.2020.05.001) (PMID:32387091)
Kohli-Lynch, C. N., Bellows, B. K., Thanassoulis, G., Zhang, Y., Pletcher, M. J., Vittinghoff, E., Pencina, M. J., Kazi, D., Sniderman, A. D. and Moran, A. E. (2019) Cost-effectiveness of low-density lipoprotein cholesterol level–guided statin treatment in patients with borderline cardiovascular risk. JAMA Cardiology, 4(10), pp. 969-977. (doi: 10.1001/jamacardio.2019.2851)
Kohli-Lynch, C. N., Lewsey, J. , Boyd, K. A. , French, D. D., Jordan, N., Moran, A. E., Sattar, N. , Preiss, D. and Briggs, A. H. (2022) Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease. Circulation, 145(17), pp. 1312-1323. (doi: 10.1161/CIRCULATIONAHA.121.057631) (PMID:35249370) (PMCID:PMC9022692)
Xin, Y. , Gray, E., Robles-Zurita, J. A., Haghpanahan, H. , Heggie, R., Kohli-Lynch, C., Briggs, A. , McAllister, D. A. , Lawson, K. D. and Lewsey, J. (2022) From spreadsheets to script: experiences from converting a Scottish cardiovascular disease policy model into R. Applied Health Economics and Health Policy, 20(2), pp. 149-158. (doi: 10.1007/s40258-021-00684-y) (PMID:34671930)
Kohli-Lynch, C., Thanassoulis, G., Moran, A. and Sniderman, A. D. (2020) The clinical utility of apoB versus LDL-C/non-HDL-C. Clinica Chimica Acta, 508, pp. 103-108. (doi: 10.1016/j.cca.2020.05.001) (PMID:32387091)
Kohli-Lynch, C. N., Bellows, B. K., Thanassoulis, G., Zhang, Y., Pletcher, M. J., Vittinghoff, E., Pencina, M. J., Kazi, D., Sniderman, A. D. and Moran, A. E. (2019) Cost-effectiveness of low-density lipoprotein cholesterol level–guided statin treatment in patients with borderline cardiovascular risk. JAMA Cardiology, 4(10), pp. 969-977. (doi: 10.1001/jamacardio.2019.2851)